Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

QuidelOrtho Corporation - Common Stock (NQ: QDEL )

36.01 +0.41 (+1.14%)
Streaming Delayed Price Updated: 9:37 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Free COVID Tests: What Stocks Will Benefit?
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
Via Talk Markets
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022. 
Via Talk Markets
COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests
President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to... 
Via Benzinga
QDEL Stock Alert: What Is Going on With Quidel Today?
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result. 
Via InvestorPlace
Quidel Announces Sponsorship and Community Partnership With the Chicago Blackhawks
From Quidel Corporation
Via Business Wire
Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease
From Quidel Corporation
Via Business Wire
Biotech Playbook 2021: No Help From Small Caps In Q4
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but... 
Via Talk Markets
7 Stocks to Buy to Hedge Against Omicron Variant Risks
With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD 
Via Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir... 
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Quidel Statement on the Omicron Variant
From Quidel Corporation
Via Business Wire
Biotech Stocks are Due for a Rally
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums. 
Via Talk Markets
Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference
From Quidel Corporation
Via Business Wire
Looking for Growth in Small and Mid Cap Life Science Stocks
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps. 
Via Talk Markets
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced... 
Via FinancialNewsMedia
Exposures COVID-19
Quidel Corp (QDEL) Q3 2021 Earnings Call Transcript
QDEL earnings call for the period ending October 4, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Quidel Reports Third Quarter 2021 Financial Results
From Quidel Corporation
Via Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation 
Via News Direct
Exposures COVID-19
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
From Quidel Corporation
Via Business Wire
Quidel to Hold Fiscal Third Quarter 2021 Financial Results Conference Call on November 4th, 2021
From Quidel Corporation
Via Business Wire
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 20, 2021 – USA News Group – It may have its beginning for the UK travel industry, but there are signs of the end of using... 
Via FinancialNewsMedia
Exposures COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Pediatric Lyme Disease—‘An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
From Quidel Corporation
Via Business Wire
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21 
Via News Direct
Exposures COVID-19 Product Safety
Quidel Blows Past Estimates for Q3 Revenue
COVID-19 testing volumes are up again. 
Via The Motley Fool
Exposures COVID-19
Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected
Quidel Corporation (NASDAQ: QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19 assay sales. Related:... 
Via Benzinga
Exposures COVID-19
After the Jobs Report, Investors are Looking at The Fed for Tapering Signals
Investors were in wait-and-see mode before the Employment Situation Report and then the volatility hit. Non-farm job growth was expected to be around 500,000... 
Via Benzinga
Topics Economy
Exposures Interest Rates
A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Data
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade ahead of the all-important jobs report for the month of September. Analysts expect nonfarm... 
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.